|
CRIPT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23919999999822E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.441200E-04 |
| Normal-vs-Stage2 |
7.90139999999884E-05 |
| Normal-vs-Stage3 |
1.121320E-03 |
| Normal-vs-Stage4 |
1.64070000030492E-07 |
| Stage1-vs-Stage2 |
7.906100E-02 |
| Stage1-vs-Stage3 |
8.047600E-01 |
| Stage1-vs-Stage4 |
3.622100E-04 |
| Stage2-vs-Stage3 |
1.335240E-01 |
| Stage2-vs-Stage4 |
2.339800E-01 |
| Stage3-vs-Stage4 |
4.561900E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.84730000000388E-05 |
| Normal-vs-AfricanAmerican |
1.073390E-01 |
| Normal-vs-Asian |
8.843100E-04 |
| Caucasian-vs-AfricanAmerican |
3.416000E-01 |
| Caucasian-vs-Asian |
6.096800E-01 |
| AfricanAmerican-vs-Asian |
2.505000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.13359999999829E-05 |
| Normal-vs-Female |
1.161410E-04 |
| Male-vs-Female |
1.253640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.662360E-02 |
| Normal-vs-Age(41-60Yrs) |
3.60529999998693E-06 |
| Normal-vs-Age(61-80Yrs) |
1.51904999999841E-05 |
| Normal-vs-Age(81-100Yrs) |
4.459800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.279200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.380100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.526630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.654600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.323800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.622400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.721600E-01 |
| Classical-VS-Follicular |
3.213400E-01 |
| Classical-VS-Other |
5.750000E-01 |
| Classical-VS-Normal |
5.76899999999991E-05 |
| Tall-VS-Follicular |
3.121000E-01 |
| Tall-VS-Other |
8.092800E-01 |
| Tall-VS-Normal |
3.651800E-02 |
| Follicular-VS-Other |
4.563000E-01 |
| Follicular-VS-Normal |
3.981200E-04 |
| Other-VS-Normal |
3.463800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.36730000000063E-05 |
| Normal-vs-N1 |
3.391000E-04 |
| N0-vs-N1 |
5.420000E-01 |
|
|
